SignatureFD’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58K Buy
+736
New +$3.02K ﹤0.01% 2994
2025
Q1
Sell
-652
Closed -$2.89K 3378
2024
Q4
$2.89K Buy
+652
New +$2.65K ﹤0.01% 2764
2024
Q2
Sell
-1,210
Closed -$10.5K 3189
2024
Q1
$10.5K Sell
1,210
-950
-44% -$11.5K ﹤0.01% 2279
2023
Q4
$24.7K Buy
2,160
+822
+61% +$8.13K ﹤0.01% 1818
2023
Q3
$12.9K Sell
1,338
-2,676
-67% -$26.2K ﹤0.01% 2074
2023
Q2
$42.7K Buy
4,014
+841
+27% +$9.04K ﹤0.01% 1519
2023
Q1
$33.4K Buy
3,173
+2,812
+779% +$31.5K ﹤0.01% 1594
2022
Q4
$4.47K Sell
361
-93
-20% -$1.05K ﹤0.01% 2525
2022
Q3
$5K Sell
454
-322
-41% -$3.65K ﹤0.01% 2436
2022
Q2
$9K Buy
776
+315
+68% +$3.71K ﹤0.01% 2166
2022
Q1
$6K Buy
461
+41
+10% +$470 ﹤0.01% 2405
2021
Q4
$5K Hold
420
﹤0.01% 2395
2021
Q3
$5K Sell
420
-99
-19% -$1.28K ﹤0.01% 2346
2021
Q2
$7K Buy
519
+111
+27% +$1.27K ﹤0.01% 2149
2021
Q1
$5K Buy
408
+155
+61% +$1.64K ﹤0.01% 2139
2020
Q4
$3K Sell
253
-20
-7% -$219 ﹤0.01% 2136
2020
Q3
$2K Buy
273
+209
+327% +$2.08K ﹤0.01% 2217
2020
Q2
$1K Buy
+64
New +$655 ﹤0.01% 2321

Other funds holding IRWD

SignatureFD's IRWD Position: Q1 2026 in Review

SignatureFD opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 736 shares worth $2.58K. The stake represents ﹤0.01% of the portfolio and ranks #2994 among its holdings. This is a return to the name: SignatureFD previously reported a position in IRWD as recently as Q4 2024.

SignatureFD first reported a position in IRWD in Q2 2020 and has held it in 18 quarters since. The position peaked at $42.7K in Q2 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • SignatureFD held 736 shares of Ironwood Pharmaceuticals worth $2.58K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new SignatureFD position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2994 holding.
  • SignatureFD first reported a position in Ironwood Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • SignatureFD's Ironwood Pharmaceuticals position peaked at $42.7K in Q2 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.